Uridine CAS 58-96-8 Purity ≥99.0% (HPLC) Content 98.0%-102.0% (UV) High Purity
Manufacturer with High Purity and Stable Quality
Chemical Name: Uridine
CAS: 58-96-8
High Quality, Commercial Production
Name | Uridine |
CAS Number | 58-96-8 |
CAT Number | RF-PI191 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C9H12N2O6 |
Molecular Weight | 244.20 |
Storage Temperature | Room Temperature |
Solubility | H2O: 50 mg/mL |
Shipping Condition | Shipped Under Ambient Temperature |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White or Almost White Crystalline Powder |
Identification | Have the largest absorption at 262±2nm wavelength and the minimum absorption at 231±2nm A250/A260=0.70~0.80 A280/A260=0.32~0.38 |
Clarity and Color of Solution | Clarity |
Melting Point | 162.0~171.0℃ |
Loss on Drying | ≤0.50% |
Specific Rotation | +6.0°~+10.0° |
Heavy Metals(Pb) | ≤10ppm |
Residue on Ignition | ≤0.10% |
Purity / Analysis Method | ≥99.0% (HPLC) |
Content / Analysis Method | 98.0%~102.0% (UV) (Dry Basis) |
Test Standard | Enterprise Standard |
Usage | Pharmaceutical Intermediates; Organic Synthesis |
Upstream Products | Uracil CAS: 66-22-8 |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Uridine (CAS: 58-96-8) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and API. Uridine (CAS: 58-96-8) is a nucleoside, it is one of the four basic components of ribonucleic acid (RNA). It is used for giant red blood cell anemia. It can also be combined with other nucleosides and bases to treat liver, cerebrovascular and cardiovascular diseases. It is used as a precursor in the production of CDP-choline. Uridine is an important nutrient and widely used as a dietary supplement.
Uridine (CAS: 58-96-8) can be used as the raw material in the synthesis of Molnupiravir (CAS 2349386-89-4) in the treatment of COVID-19.